Article
A study of prospective surveillance for inhibitors among persons with haemophilia in the United States.
Haemophilia : the official journal of the World Federation of Hemophilia - 1 Mar 2014
Soucie J M, Miller C H, Kelly F M, Payne A B, Creary M, Bockenstedt P L, Kempton C L, Manco-Johnson M J, Neff A T
Abstract excerpt
Inhibitors are a rare but serious complication of treatment of patients with haemophilia. Phase III clinical trials enrol too few patients to adequately assess new product inhibitor risk. This project explores the feasibility of using a public health surveillance system to conduct national surveillance for inhibitors. Staff at 17 U.S. haemophilia treatment centres (HTC) enrolled patients with haemophilia A and B...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.